Johnson & Johnson
Market cap $634.8B
$263.40
JNJ
$263.40
+1.59% today
Buy with €1M virtual cash · No real money
Johnson & Johnson (JNJ) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates JNJ a Buy, with the stock up 56% over the past year. You can practice trading JNJ risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$634.8B
Volume
6.4M
52-wk High
$269.43
52-wk Low
$164.23
Day High
$263.71
Day Low
$259.61
P/E (TTM)
30.56
Revenue (TTM)
$97.9B
EPS (TTM)
$8.62
Performance
1M
+9.3%
6M
+20.6%
1Y
+55.8%
Invest signal · JNJ
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
JNJ overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +5.2%Revenue
$25BEPS (diluted)
$2.27 per shareLatest JNJ news
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
The Motley Fool · 13h ago
Does PayPal Have a Buyer?
The Motley Fool · 2d ago
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - Analysis by Product, Surgery, End User and Region
GlobeNewswire Inc. · 2d ago
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It
The Motley Fool · 2d ago
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
The Motley Fool · 3d ago
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023.
After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Employees
140,800
30-Day Win Rate · JNJ
15 days
8 days
Last 23 sessions
How to practice trading JNJ
- 1
Use the JNJ buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top JNJ traders on Invest
Full leaderboardFrequently asked questions
Is JNJ a good stock to buy right now?
As of July 27, 2026, Invest's signal rates JNJ a Buy, based on its price trend, valuation, and fundamentals (P/E around 30.6), with the stock up 56% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading JNJ risk-free first.
What is Johnson & Johnson's (JNJ) market cap?
Johnson & Johnson has a market capitalization of approximately $634.8B, on trailing-twelve-month revenue of about $97.9B.
How has JNJ stock performed?
JNJ is up 56% over the past year and up 21% over six months. Its 52-week range runs roughly from $164.23 to $269.43. Past performance doesn't predict future results.
How can I practice trading JNJ for free?
On Invest you get €1,000,000 in virtual cash and can buy JNJ at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare JNJ with peers